467
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Level of Adherence and Associated Factors Among HIV-Infected Patients on Antiretroviral Therapy in Northern Ethiopia: Retrospective Analysis

ORCID Icon, , , ORCID Icon, , , ORCID Icon, , & show all
Pages 1585-1594 | Published online: 03 Sep 2020

References

  • WHO. Antiretroviral therapy. Geneva: WHO. Available from: https://www.who.int/hiv/topics/treatment/art/en/. Accessed May 22, 2020.
  • World Health Organization. Antiretroviral Therapy (ART) Coverage Among All Age Groups. Switzerland, Genieva: WHO; 2017.
  • Weiler G. Global update on HIV treatment 2013: results, impact and opportunities. Kuala Lumpur, Malaysia: International AIDS Soiety (IAS); 2013. Available from: http://www.who.int/hiv/event s/2013/1_weile r_repor t_ias_v5. pdf.
  • UNAIDS. Over view in Ethiopia. Geneva: UNAIDS; 2018. Available from: https://www.unaids.org/en/regionscountries/countries/ethiopia. Accessed Feb 27, 2020.
  • Wandeler G, Johnson LF, Egger M. Trends in life expectancy of HIV-positive adults on ART across the globe: comparisons with general population. Curr Opin HIV AIDS. 2016;11(5):492–500. doi:10.1097/COH.0000000000000298.
  • Sutton SS, Magagnoli J, Hardin JW. Odds of viral suppression by single-tablet regimens, multiple-tablet regimens, and adherence level in HIV/AIDS patients receiving antiretroviral therapy. Pharmacotherapy. 2017;37(2):204–213. doi:10.1002/phar.1889
  • Amico KR, Toro-Alfonso J, Fisher JD. An empirical test of the information, motivation and behavioral skills model of antiretroviral therapy adherence. AIDS Care. 2005;17(6):661–673. doi:10.1080/09540120500038058
  • Sarna A, Luchters S, Geibel S, Munyao P, Kaai S. Promoting Adherence to Antiretroviral Therapy Through a Directly Administered Antiretroviral Therapy (DAART) Strategy in Mombasa, Kenya. Nairobi, Kenya: Horizons Research Update, Population Council; 2005.
  • Gunthard HF, Aberg JA, Eron JJ, et al. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the international antiviral society-USA panel. JAMA. 2014;312(4):410–425. doi:10.1001/jama.2014.8722
  • Williams B, Wood R, Dukay V, et al. Treatment as prevention: preparing the way. J Int AIDS Soc. 2011;14(Suppl 1):S6. doi:10.1186/1758-2652-14-S1-S6
  • Coetzee B, Kagee A, Bland R. Barriers and facilitators to paediatric adherence to antiretroviral therapy in rural South Africa: a multi-stakeholder perspective. AIDS Care. 2015;27(3):315–321. doi:10.1080/09540121.2014.967658
  • Reda AA, Biadgilign S. Determinants of adherence to antiretroviral therapy among HIV-infected patients in Africa. AIDS Res Treat. 2012;2012.
  • Mehta K, Ekstrand M, Heylen E, Sanjeeva G, Shet A. Adherence to antiretroviral therapy among children living with HIV in South India. AIDS Behav. 2016;20(5):1076–1083. doi:10.1007/s10461-015-1207-7
  • UNAIDS. 90-90-90: treatment for all. Geneva: UNAIDS. Available from: https://www.unaids.org/en/resources/909090. Accessed May 22, 2020.
  • Desta AA, Wubayehu Woldearegay T, Berhe AA, Futwi N, Gebremedhn Gebru G, Godefay H. Immunological recovery, failure and factors associated with CD-4 T-cells progression over time, among adolescents and adults living with HIV on antiretroviral therapy in northern Ethiopia: a retrospective cross sectional study. PLoS One. 2019;14(12):e0226293. doi:10.1371/journal.pone.0226293
  • Desta AA, Mehari KK, Berhe AA, et al. Prediction of CD4 T-lymphocyte count using who clinical staging among ART-naïve HIV-infected adolescents and adults in northern ethiopia: a retrospective study. AIDS Res Treat. 2020;2020:2163486.
  • Desta AA, Woldearegay TW, Futwi N, et al. HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study. BMC Infect Dis. 2020;20(4). doi:10.1186/s12879-019-4732-6.
  • Federal Ministry of Health (FMOH) Ethiopia. National Consolidated Guidelines for Comprehensive Hiv Prevention, Care and Treatment. Addis Ababa: FMOH Ethiopia; 2018.
  • WHO. Scaling up priority HIV/AIDS interventions in the health sector, progress report: towards universal access. Available from: www.who.int/hiv/mediacentre/universal_access_progress_report_en.pdf. Accessed April 10, 2020.
  • Lencha B, Hasen K, Getachew K, Abdi M, Habtamu M. Adherence to antiretroviral therapy and associated factors among people living with HIV/AIDS at gobba hospital, southeast ethiopia: an institutional based study. Qual Prim Care. 2015;23(6):336–341.
  • Letta S, Demissie A, Oljira L, Dessie Y. Factors associated with adherence to antiretroviral therapy (ART) among adult people living with HIV and attending their clinical care, Eastern Ethiopia. BMC Int Health Hum Rights. 2015;15(1):33. doi:10.1186/s12914-015-0071-x.
  • Legesse TA, Reta MA. Adherence to antiretroviral therapy and associated factors among people living with HIV/AIDS in Hara town and its surroundings, North-Eastern Ethiopia: a cross-sectional study. Ethiop J Health Sci. 2019;29(3):299–308. doi:10.4314/ejhs.v29i3.2.
  • Molla AA, Gelagay AA, Mekonnen HS, Teshome D. Adherence to antiretroviral therapy and associated factors among HIV positive adults attending care and treatment in University of Gondar Referral Hospital, Northwest Ethiopia. BMC Infect Dis. 2018;18(1):266. doi:10.1186/s12879-018-3176-8.
  • Teshome W, Belayneh M, Moges M, et al. Who Takes the Medicine? Adherence to Antiretroviral Therapy in Southern Ethiopia. Vol. 2015. Dove Medical Press Limited; 2015:9 Pages 1531—1537. doi: 10.2147/PPA.S9081.
  • Mengistie A, Birhane A, Tesfahun E. Assessment of adherence to antiretroviral therapy among adult people living with HIV/AIDS in North East, Ethiopia. Appl Microb Res. 2019;2(2):21–27.
  • Anthony N. Factors that influence non-adherence to antiretroviral therapy among HIV and AIDs patients in central province, Kenya; 2011. Available from: http://ir-library.ku.ac.ke/handle/123456789/1725. Accessed August 21, 2020.
  • Elul B, Basinga P, Nuwagaba-Biribonwoha H, et al. High levels of adherence and viral suppression in a nationally representative sample of HIV-infected adults on antiretroviral therapy for 6, 12 and 18 months in Rwanda. PLoS One. 2013;8(1):e53586. doi:10.1371/journal.pone.0053586.
  • MacDonell K, Naar-King S, Huszti H, Belzer M. Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV. AIDS Behav. 2013;17(1):86–93. doi:10.1007/s10461-012-0364-1.
  • Rudy BJ, Murphy DA, Harris DR, Muenz L, Ellen J. Prevalence and interactions of patient-related risks for nonadherence to antiretroviral therapy among perinatally infected youth in the United States. AIDS Patient Care STDS. 2010;24(2):97–104. doi:10.1089/apc.2009.0198
  • Mhalu A, Leyna GH, Mmbaga EJ. Risky behaviours among young people living with HIV attending care and treatment clinics in Dar Es Salaam, Tanzania: implications for prevention with a positive approach. J Int AIDS Soc. 2013;16(1):17342. doi:10.7448/IAS.16.1.17342
  • Heestermans T, Browne JL, Aitken SC, Vervoort SC, Klipstein-Grobusch K. Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub- Saharan Africa: a systematic review. BMJ Glob Health. 2016;1(4):e000125. doi:10.1136/bmjgh-2016-000125.
  • Bucciardini R, Fragola V, Abegaz T, et al. Retention in care of adult hiv patients initiating antiretroviral therapy in tigray, Ethiopia: a prospective observational cohort study. PLoS One. 2015;10(9):e0136117. doi:10.1371/journal.pone.0136117
  • Jobanputra K, Parker LA, Azih C, et al. Factors associated with Virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland. PLoS One. 2015;10(2):e0116144. doi:10.1371/journal.pone.0116144.
  • Penot P, He’ma A, Bado G, et al. The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso. JIAS. 2014;17(1):18646. doi:10.7448/IAS.17.1.18646
  • Fonsah JY, Njamnshi AK, Kouanfack C, et al. Adherence to antiretroviral therapy (ART) in yaounde´-cameroon: association with opportunistic infections, depression, ART regimen and side effects. PLoS One. 2017;12(1):e0170893. doi:10.1371/journal.pone.0170893.
  • Wang H, Zhou J, Zhou J, et al. Consistent ART adherence is associated with improved quality of life, CD4 counts, and reduced hospital costs in Central China. AIDS Res Hum Retrovir. 2009;25(8):757–763. doi:10.1089/aid.2008.0173.
  • Kalichman SC, Grebler T, Amaral CM, et al. Viral suppression and antiretroviral medication adherence among alcohol using HIV positive adults. Int J Behav Med. 2014;21(5):811–820. doi:10.1007/s12529-013-9353-7.